Mereo BioPharma Group Plc (MREO)

0.2755 +0.01 (+3.11%) USD  |  NASDAQ  |  Sep 03, 16:00
0.2755 0.00 (0.00%) After-Hours: 16:11
More

Mereo BioPharma Group Cost of Goods Sold (% of Quarterly Revenues)

Cost of Goods Sold (% of Quarterly Revenues) Chart

View Cost of Goods Sold (% of Quarterly Revenues) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cost of Goods Sold (% of Quarterly Revenues) Chart
Start Trial

Historical Cost of Goods Sold (% of Quarterly Revenues) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2025 --

Cost of Goods Sold Definition

Returns the Cost of Goods Sold (COGS) for the period and date(s) requested in local currency by default.

Read full definition.

Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years

View Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cost of Goods Sold (% of Quarterly Revenues) Benchmarks

View Cost of Goods Sold (% of Quarterly Revenues) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
NuCana Plc --
BioNTech SE Upgrade
Silence Therapeutics Plc Upgrade
Autolus Therapeutics Plc Upgrade